(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Pudendal Neuralgia
University of LouisvilleSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Pudendal Neuralgia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Groupe Hospitalier Diaconesses Croix Saint-Simon | Phase 4 | BBB |
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION Nantes University Hospital | Phase 4 | BB |
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- Cairo University | N/A | D |
Same molecule, other indications
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →